Michael Baran

Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.

Raised $32,000,000,000.00 from Starboard Value.

Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders

Raised $208,700,000.00 from GT Healthcare Capital Partners, Samsara BioCapital, ARCH Venture Partners, Biotechnology Value Fund, Monograph Capital, Insight Partners, Newpath Management, Canaan Partners, Bristol-Myers Squibb and Pfizer Venture Investments.

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

Raised $105,000,000.00 from Pureos Bioventures, Novartis Venture Fund, Mass General Brigham Ventures, Ono Venture Investment, Mission BioCapital, Pfizer Venture Investments, Gimv, Sofinnova Partners, Eli Lilly & Company Foundation and Bristol-Myers Squibb.

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Raised $154,383,867.00 from Penn Medicine Co-Investment Program, Agent Capital, The Mark Foundation for Cancer Research, Cormorant Asset Management, Quan Capital, BrightEdge Fund, OUP (Osage University Partners), RA Capital Management, Logos Capital and Pfizer Venture Investments.